|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
79628007X |
003 |
DE-627 |
005 |
20230905071748.0 |
007 |
tu |
008 |
140904s2015 xxu||||| 00| ||eng c |
020 |
|
|
|a 9781493913985
|9 978-1-4939-1398-5
|
035 |
|
|
|a (DE-627)79628007X
|
035 |
|
|
|a (DE-599)BVBBV042051828
|
035 |
|
|
|a (OCoLC)915554876
|
035 |
|
|
|a (DE-604)BV042051828
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
044 |
|
|
|c XD-US
|c XA-DE
|c XA-NL
|
050 |
|
0 |
|a RM301.25
|
082 |
0 |
|
|a 615.1
|q LOC
|2 23
|
084 |
|
|
|a 15,3
|2 ssgn
|
084 |
|
|
|a VX 8550
|q BVB
|2 rvk
|0 (DE-625)rvk/147830:253
|
084 |
|
|
|a 44.40
|2 bkl
|
084 |
|
|
|a 58.28
|2 bkl
|
245 |
1 |
0 |
|a Discovering and developing molecules with optimal drug-like properties
|c A. C. Templeton ... Eds.
|
264 |
|
1 |
|a New York, NY [u.a.]
|b Springer [u.a.]
|c 2015
|
300 |
|
|
|a XI, 511 S.
|b Ill., graph. Darst.
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
490 |
1 |
|
|a AAPS advances in the pharmaceutical sciences series
|v 15
|
500 |
|
|
|a Literaturangaben
|
650 |
|
0 |
|a Drugs
|x Research
|
650 |
|
0 |
|a Drugs
|x Design
|
689 |
0 |
0 |
|D s
|0 (DE-588)4003120-2
|0 (DE-627)106390600
|0 (DE-576)208850341
|a Arzneimittelforschung
|2 gnd
|
689 |
0 |
1 |
|D s
|0 (DE-588)4143176-5
|0 (DE-627)104408812
|0 (DE-576)209724234
|a Arzneimittelentwicklung
|2 gnd
|
689 |
0 |
2 |
|D s
|0 (DE-588)4045699-7
|0 (DE-627)104162406
|0 (DE-576)209066407
|a Pharmazeutische Technologie
|2 gnd
|
689 |
0 |
3 |
|D s
|0 (DE-588)4246877-2
|0 (DE-627)104809191
|0 (DE-576)210483121
|a Formulierung
|g Technische Chemie
|2 gnd
|
689 |
0 |
|
|5 (DE-627)
|
700 |
1 |
|
|a Templeton, A. C.
|e hrsg
|4 edt
|
776 |
1 |
|
|z 9781493913992
|
810 |
2 |
|
|a American Association of Pharmaceutical Scientists
|t AAPS advances in the pharmaceutical sciences series
|v 15
|9 15
|w (DE-627)674628586
|w (DE-576)9674628584
|w (DE-600)2639433-9
|x 2210-7371
|7 ns
|
856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/79628007X.pdf
|m V:DE-601
|m B:DE-84
|q application/pdf
|v 2017-08-03
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a ISIL_DE-84
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a SSG-OPC-DE-84
|
936 |
r |
v |
|a VX 8550
|b Allgemeines
|k Chemie und Pharmazie
|k Pharmazeutische Technologie einschl. Biopharmazie
|k Pharmazeutische Technologie allgemein
|k Pharmakokinetik
|k Allgemeines
|0 (DE-627)1271728699
|0 (DE-625)rvk/147830:253
|0 (DE-576)201728699
|
936 |
b |
k |
|a 44.40
|j Pharmazie
|j Pharmazeutika
|0 (DE-627)106423304
|
936 |
b |
k |
|a 58.28
|j Pharmazeutische Technologie
|0 (DE-627)106417622
|
951 |
|
|
|a BO
|
953 |
|
|
|2 045F
|a 615.1
|
980 |
|
|
|2 20
|1 01
|x 0084
|b 1506105386
|c 00
|f --%%--
|d 2937-2120
|e --%%--
|j --%%--
|y k
|z 10-12-14
|
984 |
|
|
|2 20
|1 01
|x 0084
|a 84$029372120
|